Impacto de la percepción de riesgo de padecer cáncer en Consejo Genético Oncológico
- Olivera Pérez-Frade, Helena
- Olivares Crespo, María Eugenia
- Cruzado Rodríguez, Juan Antonio
- Brenes Sánchez, Juana
- Herrera de la Muela, María
- Pérez Segura, Pedro
ISSN: 1696-7240
Argitalpen urtea: 2022
Alea: 19
Zenbakia: 2
Orrialdeak: 269-281
Mota: Artikulua
Beste argitalpen batzuk: Psicooncología: investigación y clínica biopsicosocial en oncología
Laburpena
The cancer genetic counseling oncology helps for detecting families at high risk for hereditary breast/ovarian cancer, due to BRCA1/2 pathogenic mutations. Objective: To assess the perception of cancer risk in women with a personal and/or family history of hereditary breast/ovarian cancer, assess the perception of risk based on the detection of the presence/absence of a pathogenic mutation, and the preventive measure chosen after completion of the study genetic (periodic follow-up or risk-reducing surgery). Method: an assessment of sociodemographic and clinical variables and perception of cancer risk was carried out retrospectively in a group of women carriers of the mutation who underwent genetic testing since 1998, and prospectively in a group of women who underwent genetic testing since 2015. The global sample was made up of 262 women (173 newly studied women and 89 previously studied mutation carrier women). Result: Significant differences were found in women who decided to opt for risk-reducing surgery, who presented a higher risk perception than those who chose follow-up, and a significant decrease in this perception was observed after carrying out the surgery. Conclusions: It is necessary to evaluate the perception of risk of the participants in CGO.
Erreferentzia bibliografikoak
- 1. Genetic counseling. Am J Hum Genet 1975;27:240-2.
- 2. Teulé A, Lázaro C. Genes de predisposición hereditaria al cáncer y riesgo poligénico. En: Sociedad Española de Oncología Médica. Cáncer Hereditario. 3ª Ed. Madrid: SEOM, 2019. p.31-43.
- 3. Llort G, Ramón y Cajal T. Aspectos clínicos de predisposición hereditaria al cáncer de mama y al cáncer de ovario. En: Sociedad Española de Oncología Médica. Cáncer Hereditario. Tercera Edición. Madrid: SEOM, 2019. p. 155-188.
- 4. Pujol P, Barberis M, Beer P, Friedman E, Piulats JM, Capoluongo ED, et al. Clinical practice guidelines for BRCA1 and BRCA2 genetic testing. Eur J Cancer 2021;146:30- 47. https://doi.org/10.1016/j.ejca.2020.12.023.
- 5. Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, et al. Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 20216;19:77-102. https://doi. org/10.6004/jnccn.2021.0001.
- 6. Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med 2014; 18;160:255-66. https://doi.org/10.7326/M13-1684.
- 7. Sekine M, Nishino K, Enomoto T. BRCA Genetic test and risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancer: state-of-the-art. Cancers (Basel) 2021;23;13:2562. https://doi.org/10.3390/cancers13112562.
- 8. Gettig E, Marks J, Mulvihill J. Genetic counseling for the oncology patient. In: Holland JC, editor. Psycho-oncology. New York: Oxford University Press; 1998. p. 186–195.
- 9. Coyne JC, Benazon NR, Gaba CG, Calzone K, Weber BL. Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families. J Consult Clin Psychol 2000;68:864-74.
- 10. Shin S, Ryu MR, Kwon WK, Kim S, Jang J-H, Kim J-W. Psychological effects and risk perception after genetic counselling. J Gen Med 2021;18:38-43. https://doi.org/10.5734/ JGM.2021.18.1.38
- 11. Butow PN, Lobb EA, Meiser B, Barratt A, Tucker KM. Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review. Med J Aust 2003; 20;178:77-81. https://doi.org/10.5694/j.1326-5377.2003.tb05069.x.
- 12. Gomes P, Pietrabissa G, Silva ER, Silva J, Matos PM, Costa ME, Bertuzzi V, Silva E, Neves MC, Sales CMD. Family adjustment to hereditary cancer syndromes: a systematic review. Int J Environ Res Public Health 2022; 30;19:1603. https://doi.org/10.3390/ ijerph19031603.
- 13. Hassanein Z, Lee R, Ahmed M, Asgeirsson K, Macmillan D, Wilson E. Experiencies and views of women undergoing BRCA genetic testing in the UK: A qualitative systematic review. Eur J Surg Oncol 2022; 48: E193. https://doi.org/10.1016/j.ejso.2022.03.036
- 14. den Heijer M, Seynaeve C, Vanheusden K, Timman R, Duivenvoorden HJ, Tilanus-Linthorst M, et al. Long-term psychological distress in women at risk for hereditary breast cancer adhering to regular surveillance: a risk profile. Psychooncology 2013;22:598- 604. https://doi.org/10.1002/pon.3039.